RSVP to Help Inform Future FTD Treatments
On March 5, 2021 AFTD will host a virtual Externally Led Patient-Focused Drug Development (EL-PFDD) meeting with representatives of the U.S. Food and Drug Administration.
The FDA uses these meetings to better understand diseases like FTD, and it represents a unique opportunity to make your voice heard.
We encourage people with FTD – and all whose lives have been personally affected by this disease — to participate in this vital, free event.
Professionals working in research, healthcare, nonprofit and government settings are invited to listen in on this free, open meeting as silent participants, to hear directly from the community we all serve.
Click here to learn more about the EL-PFDD meeting.